In this study, we aimed to obtain causal estimates of the relationship between circulating GCKR levels and GDM and mediating effects while assessing the impacts of GCKR on GDM‐related complications to comprehensively evaluate the genetic evidence for GCKR as a therapeutic target. The gene discussed is GCKR; the disease is gestational diabetes.